Yazar "Dayangac, Murat" seçeneğine göre listele
Listeleniyor 1 - 5 / 5
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Covid-19 in Liver Transplant Recipients: A National Cohort(Elsevier, 2021) Kabacam, Gokhan; Turan, Ilker; Kiyici, Murat; Ellik, Zeynep Melekoglu; Dolu, Suleyman; Dayangac, Murat; Ari, Derya[No Abstract Available]Öğe The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists(Aves, 2020) Kabacam, Gokhan; Dayangac, Murat; Ucbilek, Enver; Ercin, Cemal Nuri; Gunsar, Fuiya; Akyilchz, Murat; Idilmanw, RamazanCoronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a novel acute infectious disease that has rapidly reached staggering pandemic proportions. This review addresses gastroenterologists, hepatologists, liver transplant (LT) specialists, and health-care professionals working in the field of liver diseases and liver transplantation. It has been written based on a limited number of publications, recommendations of national and international liver and organ transplantation societies, and experiences of patients with COVID-19 around the world. the purpose of this review is to provide information addressing questions and concerns about COVID-19, to reveal the effects of the novel disease on patients with chronic liver disease and LT recipients, and to share information about ways in which this pandemic will affect clinical practices. We, the Turkish Association for the Study of the Liver (TASL), would like to remind you that this text is actually not a practical guide. It is imperative to act according to the standards set by health-care institutions and the Ministry of Health, Republic of Turkey.Öğe Glasgow coma scale and APACHE-II scores affect the liver transplantation outcomes in patients with acute liver failure(Zhejiang Univ Sch Medicine, 2013) Guler, Necdet; Unalp, Omer; Guler, Ayse; Yaprak, Onur; Dayangac, Murat; Sozbilen, Murat; Akyildiz, Murat; Tokat, YamanBACKGROUND: The timing and selection of patients for liver transplantation in acute liver failure are great challenges. This study aimed to investigate the effect of Glasgow coma scale (GCS) and APACHE-II scores on liver transplantation outcomes in patients with acute liver failure. METHOD: A total of 25 patients with acute liver failure were retrospectively analyzed according to age, etiology, time to transplantation, coma scores, complications and mortality. RESULTS: Eighteen patients received transplants from live donors and 7 had cadaveric whole liver transplants. The mean duration of follow-up after liver transplantation was 39.86 +/- 40.23 months. Seven patients died within the perioperative period and the 1-, 3-, 5-year survival rates of the patients were 72%, 72% and 60%, respectively. The parameters evaluated for the perioperative deaths versus alive were as follows: the mean age of the patients was 33.71 vs 28 years, MELD score was 40 vs 32.66, GCS was 5.57 vs 10.16, APACHE-II score was 23 vs 18.11, serum sodium level was 138.57 vs 138.44 mmol/L, mean waiting time before the operation was 12 vs 5.16 days. Low GCS, high APACHE-II score and longer waiting time before the operation (P<0.01) were found as statistically significant factors for perioperative mortality. CONCLUSION: Lower GCS and higher APACHE-II scores are related to poor outcomes in patients with acute liver failure after liver transplantation.Öğe Precipitating Factors for Lymphedema Following Surgical Treatment of Breast Cancer: Implications for Patients Undergoing Axillary Lymph Node Dissection(Wiley-Blackwell Publishing, Inc, 2009) Dayangac, Murat; Makay, Oezer; Yeniay, Levent; Aynaci, Murat; Kapkac, Murat; Yilmaz, RasihÖğe Using marginal right lobe living liver donors: Safety of expanding the margins(Blackwell Publishing, 2007) Dayangac, Murat; Taner, Burcin C.; Akin, Baris E.; Balci, Deniz; Uraz, Suleyman; Duran, Cihan; Killi, Refik; Ayanoglu, Omer H.; Yuzer, Yildiray; Tokat, Yaman
